ANN MOORE: Open Payments
NPI 1184840712 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,062 in 159 payments from 11 companies in 2025. Trend: 2023 $39,659 · 2024 $71,467 · 2025 $49,062
Speaker / faculty: $23,691Consulting: $12,283Travel & lodging: $6,073Food & beverage: $4,926Speaker / faculty: $1,330Honoraria: $760
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 25 | $14,047 |
| ABBVIE INC. | 35 | $7,924 |
| Gilead Sciences, Inc. | 36 | $7,404 |
| Madrigal Pharmaceuticals | 27 | $6,433 |
| Siemens Medical Solutions USA, Inc. | 5 | $4,910 |
| Intercept Pharmaceuticals, Inc. | 8 | $3,108 |
| GlaxoSmithKline, LLC. | 2 | $3,000 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $1,161 |
| Novo Nordisk Inc | 2 | $1,009 |
| ORPHALAN INC | 2 | $39 |
Products named: IQIRVO, MAVYRET, REZDIFFRA, Atellica IM 1300 Analyzer, Epclusa, OCALIVA, Bylvay, Livdelzi.
Industry payments across AZ — which companies pay providers there.
